Mechanistic insights into dengue virus inhibition by a clinical trial compound NITD-688

Proceedings of the National Academy of Sciences, Volume 122, Issue 13, April 2025.
SignificanceDengue virus (DENV) is the most important mosquito-borne flavivirus affecting humans, yet no effective therapies exist. NITD-688 represents a promising panserotype DENV drug candidate currently in Phase II clinical trials. Understanding the …
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

This website is using cookies to improve the user-friendliness. You agree by using the website further.

Privacy policy
Skip to content